CELL FREE GENOMICS Information

Our vision is to develop and bring to the clinic a new generation of high-accuracy, non-invasive prenatal solutions that provide broader and more reliable genetic insights from a single blood sample. By integrating cutting-edge genomics, advanced bioinformatics, and clinical expertise, we aim to simplify prenatal testing while improving accuracy, safety, and clinical value for expectant families and healthcare professionals. CELL FREE GENOMICS focuses on transforming prenatal screening by: - Expand the clinical scope of non-invasive prenatal testing beyond current standard approaches. - Improve accuracy and reliability across a wider range of genetic conditions. - Simplify clinical workflows by reducing the need for multiple tests. - Enhance patient experience through safer, non-invasive solutions. - Our work is guided by strong scientific foundations, regulatory readiness, and a commitment to clinical excellence. Through continuous research and development, CELL FREE GENOMICS seeks to contribute to better pregnancy care, improved neonatal outcomes, and the future of precision medicine in reproductive health. Our approach is designed to support both centralized diagnostic services and future strategic partnerships. Driven by scientific excellence, clinical relevance, and long-term value creation, CELL FREE GENOMICS is positioned at the intersection of genomics, precision medicine, and maternal-fetal health, with the goal of delivering meaningful impact for patients, clinicians, healthcare systems, and investors alike.